FDA Inspection
Navinta, LLCNavinta, LLC – FDA Inspection, Sep 18, 2018
Record Details
This FDA Inspection record concerns Navinta, LLC, with an inspection on September 18, 2018, issued by the New Jersey District Office, covering human drugs.
View Company Profile
ID · 89d9cbd4-879b-471f-8a04-efacf0821bff
Inspection Facts
- Inspection number
- 1070302
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Navinta, LLC
7| Date | Classification | Office | Project area |
|---|---|---|---|
| September 30, 2024 | Not classified | New Jersey District Office | |
| June 29, 2023 | Not classified | New Jersey District Office | |
| May 4, 2023 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| March 28, 2019 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| August 18, 2017 | VAI | Center for Drug Evaluation and Research | Postmarket Surv. and Epidemiology |
Other documents for Navinta, LLC
- FDA Inspection 1252822 - 2024-09-30
- FDA Inspection 1209856 - 2023-06-29
- FDA Inspection 1205480 - 2023-05-04
- FDA Inspection 1084188 - 2019-03-28
- FDA Inspection 1022105 - 2017-08-18
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.